News and Announcements
QBiotics Share Offer Oversubscribed by $4.3m
- Published October 12, 2016 3:30PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Long term Axstra client QBiotics Limited has successfully raised in $16.8 million from its latest round of capital raising. The Company’s Prospectus Share Offer was oversubscribed by $4.3m following high demand from investors. In light of the interest in QBiotics, a Private Placement was also successfully implemented.
The new capital places QBiotics in a strong financial position moving forward with over AU$30 million in the bank. Current emphasis is on finalising product development and market launch preparation of the anticancer drug EBC-46 for the USA and UK veterinary market, and development of QBiotics’ wound healing treatment WH-1 for human diabetic foot ulcers and venous leg ulcers.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
